Latest Insider Transactions at Amicus Therapeutics, Inc. (FOLD)
This section provides a real-time view of insider transactions for Amicus Therapeutics, Inc. (FOLD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AMICUS THERAPEUTICS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AMICUS THERAPEUTICS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 01
2023
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,700
+0.7%
|
$23,400
$2.7 P/Share
|
Jun 01
2023
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
6,044
-0.63%
|
$66,484
$11.36 P/Share
|
May 18
2023
|
Glenn Sblendorio |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+14.75%
|
$45,000
$3.32 P/Share
|
May 15
2023
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
6,044
-0.62%
|
$66,484
$11.18 P/Share
|
May 01
2023
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
6,044
-0.62%
|
$66,484
$11.8 P/Share
|
May 01
2023
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
11,700
-1.4%
|
$128,700
$11.8 P/Share
|
May 01
2023
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,700
+1.38%
|
$23,400
$2.45 P/Share
|
Apr 17
2023
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
6,044
-0.62%
|
$66,484
$11.66 P/Share
|
Apr 03
2023
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
11,700
-1.4%
|
$128,700
$11.21 P/Share
|
Apr 03
2023
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,700
+1.38%
|
$23,400
$2.45 P/Share
|
Apr 03
2023
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
6,044
-0.61%
|
$66,484
$11.22 P/Share
|
Mar 17
2023
|
Michael Raab |
SELL
Open market or private sale
|
Direct |
4,408
-6.84%
|
$48,488
$11.33 P/Share
|
Mar 17
2023
|
Michael Raab |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+18.89%
|
$45,000
$3.32 P/Share
|
Mar 15
2023
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,375
-1.6%
|
$147,125
$11.43 P/Share
|
Mar 15
2023
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
6,044
-0.61%
|
$66,484
$11.34 P/Share
|
Mar 01
2023
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
6,044
-0.3%
|
$78,572
$13.49 P/Share
|
Mar 01
2023
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
20,000
-1.17%
|
$260,000
$13.4 P/Share
|
Mar 01
2023
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,700
+1.35%
|
$23,400
$2.45 P/Share
|
Feb 15
2023
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
6,044
-0.6%
|
$72,528
$12.94 P/Share
|
Feb 01
2023
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
147,316
-12.79%
|
$1,915,108
$13.11 P/Share
|
Feb 01
2023
|
John F Crowley Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
139,929
+5.88%
|
$699,645
$5.62 P/Share
|
Feb 01
2023
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
20,000
-2.31%
|
$240,000
$12.98 P/Share
|
Feb 01
2023
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,700
+1.33%
|
$23,400
$2.45 P/Share
|
Jan 24
2023
|
Ellen Rosenberg Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
31,839
-8.74%
|
$413,907
$13.32 P/Share
|
Jan 18
2023
|
Daphne Quimi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,923
-1.71%
|
$89,999
$13.0 P/Share
|
Jan 18
2023
|
David Michael Clark Chief People Officer |
SELL
Open market or private sale
|
Direct |
7,382
-2.97%
|
$95,966
$13.5 P/Share
|
Jan 17
2023
|
Daphne Quimi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.22%
|
$60,000
$12.49 P/Share
|
Jan 13
2023
|
Margaret G Mcglynn |
SELL
Open market or private sale
|
Direct |
15,000
-22.83%
|
$195,000
$13.03 P/Share
|
Jan 13
2023
|
Margaret G Mcglynn |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+18.59%
|
$45,000
$3.32 P/Share
|
Jan 11
2023
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
50,147
-5.55%
|
$601,764
$12.02 P/Share
|
Jan 11
2023
|
Bradley L Campbell President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
98,040
+9.79%
|
-
|
Jan 11
2023
|
Jeff Castelli Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
24,325
-5.97%
|
$291,900
$12.02 P/Share
|
Jan 11
2023
|
Jeff Castelli Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
56,024
+12.09%
|
-
|
Jan 11
2023
|
David Michael Clark Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
18,738
-7.01%
|
$224,856
$12.02 P/Share
|
Jan 11
2023
|
David Michael Clark Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,621
+15.13%
|
-
|
Jan 11
2023
|
John F Crowley Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
83,261
-7.6%
|
$999,132
$12.02 P/Share
|
Jan 11
2023
|
John F Crowley Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
210,088
+16.09%
|
-
|
Jan 11
2023
|
Daphne Quimi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
29,565
-6.72%
|
$354,780
$12.02 P/Share
|
Jan 11
2023
|
Daphne Quimi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
58,824
+11.79%
|
-
|
Jan 11
2023
|
Ellen Rosenberg Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
24,185
-6.23%
|
$290,220
$12.02 P/Share
|
Jan 11
2023
|
Ellen Rosenberg Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
56,024
+12.61%
|
-
|
Jan 09
2023
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
11,700
-1.43%
|
$128,700
$11.43 P/Share
|
Jan 09
2023
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,700
+1.41%
|
$23,400
$2.45 P/Share
|
Jan 09
2023
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
85,102
-8.77%
|
$936,122
$11.43 P/Share
|
Jan 06
2023
|
David Michael Clark Chief People Officer |
SELL
Open market or private sale
|
Direct |
21,507
-8.92%
|
$236,577
$11.87 P/Share
|
Jan 04
2023
|
David Michael Clark Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,692
-1.1%
|
$32,304
$12.03 P/Share
|
Jan 04
2023
|
John F Crowley Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
10,659
-1.09%
|
$127,908
$12.03 P/Share
|
Jan 04
2023
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,094
-0.87%
|
$85,128
$12.03 P/Share
|
Jan 04
2023
|
Daphne Quimi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,884
-1.01%
|
$46,608
$12.03 P/Share
|
Jan 04
2023
|
Ellen Rosenberg Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,575
-1.06%
|
$42,900
$12.03 P/Share
|